© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Impact BioMedical Inc. (IBO) stock declined over -10.67%, trading at $0.44 on AMEX, down from the previous close of $0.49. The stock opened at $0.48, fluctuating between $0.43 and $0.51 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 0.48 | 0.51 | 0.43 | 0.44 | 269.76K |
| Sep 09, 2026 | 0.51 | 0.51 | 0.48 | 0.49 | 49.05K |
| Sep 08, 2026 | 0.51 | 0.53 | 0.50 | 0.50 | 151.02K |
| Sep 04, 2026 | 0.48 | 0.64 | 0.47 | 0.54 | 4.11M |
| Sep 03, 2026 | 0.48 | 0.49 | 0.47 | 0.48 | 82.43K |
| Sep 02, 2026 | 0.47 | 0.49 | 0.46 | 0.49 | 43.3K |
| Sep 01, 2026 | 0.48 | 0.49 | 0.46 | 0.46 | 26.68K |
| Aug 31, 2026 | 0.44 | 0.47 | 0.44 | 0.46 | 8.4K |
| Aug 28, 2026 | 0.44 | 0.46 | 0.44 | 0.44 | 6.68K |
| Aug 27, 2026 | 0.44 | 0.46 | 0.44 | 0.44 | 51.33K |
| Aug 26, 2026 | 0.45 | 0.49 | 0.44 | 0.44 | 12.5K |
| Aug 25, 2026 | 0.47 | 0.49 | 0.44 | 0.46 | 53.83K |
| Aug 24, 2026 | 0.45 | 0.48 | 0.45 | 0.45 | 14.19K |
| Aug 21, 2026 | 0.44 | 0.48 | 0.44 | 0.48 | 22.75K |
| Aug 20, 2026 | 0.43 | 0.46 | 0.43 | 0.45 | 24.41K |
| Aug 19, 2026 | 0.46 | 0.46 | 0.43 | 0.43 | 31.4K |
| Aug 18, 2026 | 0.46 | 0.48 | 0.46 | 0.47 | 26.64K |
| Aug 17, 2026 | 0.44 | 0.48 | 0.44 | 0.48 | 54.58K |
| Aug 14, 2026 | 0.42 | 0.48 | 0.41 | 0.46 | 50.13K |
| Aug 13, 2026 | 0.45 | 0.45 | 0.43 | 0.44 | 6.95K |
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.
| Employees | 2 |
| Beta | 2.76 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |